Three new movies were no match for the Ghost With the Most as “Beetlejuice Beetlejuice” loomed large over domestic box office charts again.
Tim Burton’s spooky sequel added a stellar $51.6 million in its second weekend of release, bringing its tally to $188 million in North America and $264 million globally. “Beetlejuice Beetlejuice” hasn’t resonated as strongly at the international box office, where the Warner Bros. film has earned $76.3 million to date.
In terms of newcomers, “Speak No Evil,” Universal and Blumhouse’s remake of the 2022 Danish horror film, opened in second place with $11.5 million from 3,375 venues. Provocateur comedian Matt Walsh’s satire documentary “Am I Racist?” landed in fourth place with a decent $4.75 million from 1,517 theaters. The film, released by conservative pundit Ben Shapiro’s The Daily Wire, landed the top debut in 2024 for a doc. Meanwhile, Lionsgate’s “The Killer’s Game” with Dave Bautista failed to connect, debuting at No. 6 with $2.6 million from 2,623 locations.
James McAvoy and Mackenzie Davis star in “Speak No Evil,” a pitch-black comedy of manners about a couple who invite two friends to their vacation at their idyllic, remote home in the countryside. Reviews and audience scores have been positive, which could help with word of mouth. The film also opened internationally with $9.3 million from 73 markets for a global opening of $20.8 million.
Since “Speak No Evil” cost $15 million, it’ll be decently positioned in its theatrical run. But the movie continues a humdrum year for horror, which is usually one of the most reliable big screen genres. Recent films like “Beetlejuice Beetlejuice,” Disney’s “Alien: Romulus” ($330 million) and Neon’s sleeper hit “Longlegs” ($103 million) have popped, but Blumhouse-produced offerings such as Universal’s “Night Swim” ($54 million), Lionsgate’s “Imaginary” ($39 million) and Sony’s “Afraid” ($10 million) failed to strike a nerve.
Blumhouse is known for responsible budgets, so some of those films might have managed to eke out a profit. But the company’s off year is stark because 2022 and 2023 were particularly huge for the low-budget house of scares with “Five Nights at Freddy’s” ($292 million), “Insidious 5” ($189 million), “Exorcist: Believer” ($136 million) and “M3GAN” ($180 million). In any case, analysts believe Blumhouse will return to form with 2025 sequels including “M3GAN 2.0,” “Black Phone 2” and “Five Nights at Freddy’s 2.”
“Blumhouse sets a high standard for the genre,” says David A. Gross, who runs the movie consulting firm Franchise Entertainment Research. “In a good year, dollar-for-dollar, Blumhouse might be the most profitable production company in the industry.”
Elsewhere, Disney and Marvel’s superhero sequel “Deadpool & Wolverine” slid to the No. 3 spot with $5.2 million from 3,075 theaters in its eighth weekend of release. The R-rated film, starring Ryan Reynolds and Hugh Jackman, has remained in the top three for eight consecutive weeks and has grossed a mammoth $621.5 million domestically and $1.3 billion globally to date.
Dennis Quaid’s biopic “Reagan” rounded out the top five with $2.9 million from 2,450 theaters in its third weekend on the big screen. The film, which charts the life of former president Ronald Reagan, has generated $23 million to date.
In limited release, “My Old Ass,” a coming-of-age comedy directed by Megan Park and starring Maisy Stella and Aubrey Plaza, grossed $171,242 million from seven locations across New York, Los Angeles and Austin. Those ticket sales translate to a solid $24,535 per venue. Next weekend, the Amazon MGM film will expand to 32 theaters in 10 markets followed by wide release on Sept. 26.
After this weekend, domestic box office ticket sales are 12.4% behind the same point in 2023 and 25.4% behind 2019, according to Comscore. Up next on the fall slate is Paramount’s “Transformers One” (Sept. 20), Universal and DreamWorks Animation’s “The Wild Robot” (Sept. 27), the Warner Bros. sequel “Joker: Folie à Deux” (Oct. 4) and Sony’s dramatic comedy “Saturday Night” (Oct. 11).
“This fall season is going to rely heavily on October to deliver big,” says senior Comscore analyst Paul Dergarabedian. “After starting off strong with ‘Beetlejuice Beetlejuice,’ September has unfortunately been a mixed bag.”